Symptomtext
no adverse event; received VARIVAX/that experienced a temperature excursion; This spontaneous report was received from a registered nurse referring to unknown patients of unknown age and gender. Pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 11-JUL-2022, following vaccines were administered after temperature excursion to 10.8 degree Celsius for 2 hours 27 minutes (product storage error). Names of vaccines involved: measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) (lot # U011995, expiration date: 15-APR-2023, lot # U009511 expiration date: 25-MAR-2023, lot# U014656 expiration date: 07-MAY-2023, lot # U022318, expiration date: 15-JUL-2023, lot # T025930, expiration date: 30-JUL-2022, lot # U029619, expiration date: 22-SEP-2023) for prophylaxis (strength, dose and route of administration were not provided), measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) (lot #U029319, expiration date: 19-MAR-2023, lot# U024296 expiration date 21-SEP-2023, lot# U039723 expiration date: 15-DEC-2023, lot# U015679 expiration 18-AMY-2023), varicella virus vaccine live (oka/merck) (VARIVAX) (lot #U010396, expiration date: 01-APR-2023, lot# U039723 expiration date: 15-DEC-2023, lot# U015679 expiration date: 18-MAY-2023, U024296 is an invalid lot number for varicella virus vaccine live (oka/merck) (VARIVAX) expiration date reported as 21-SEP-2023) for prophylaxis (all vaccines strength, dose, anatomical location and route of administration were not provided). The reported was unsure how many administrations occurred and did not have individual patient information. No additional adverse event was reported (no adverse event). This case is non-valid due to the number of patients was unspecified and lack of patients' identifiers. Follow-up information was received from a registered nurse on 09-AUG-2022. This case was previously considered non-valid but per follow-up it was determined to be valid (there were only 3 patients who receive the vaccines). This spontaneous report refers to a 12 month old male patient. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 13-JUL-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot # U026207, expiration date 24-AUG-2023, for prophylaxis (dose and route of administration was not provided) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) lot # U009511, expiration date 25-MAR-2023 (dose and route of administration was not provided) for prophylaxis, both experienced a temperature excursion. No adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2207USA005428: US-009507513-2208USA004875: